The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Open accessAbstract
Branch points and flexures in the high pressure arterial system have long been recognized as sites of unusually high turbulence and consequent stress in humans are foci for atherosclerotic lesions. We show that mice that are homozygous for a null mutation in the gene encoding an endogenous antiinflammatory cytokine, interleukin 1 receptor antagonist (IL-1ra), develop lethal arterial inflammation involving branch points and flexures of the aorta and its primary and secondary branches. We observe massive transmural infiltration of neutrophils, macrophages, and CD4+ T cells. Animals appear to die from vessel wall collapse, stenosis, and organ infarction or from hemorrhage from ruptured aneurysms. Heterozygotes do not die from arteritis within a year of birth but do develop small lesions, which suggests that a reduced level of IL-1ra is insufficient to fully control inflammation in arteries. Our results demonstrate a surprisingly specific role for IL-1ra in the control of spontaneous inflammation in constitutively stressed artery walls, suggesting that expression of IL-1 is likely to have a significant role in signaling artery wall damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,088
cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 889
Topper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
Bochner, B. S., Luscinskas, F. W., Gimbrone, M. A., Newman, W., Sterbinsky, S. A., Derse-Anthony, C. P., Klunk, D., & Schleimer, R. P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1553 · Cited by 651
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex
Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., & Ju, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13757 · Cited by 639
Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Interleukin 6 is involved in interleukin 1‐induced activities
Helle, M., Brakenhoff, J. P. J., Groot, E. R. D., & Aarden, L. A. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180619 · Cited by 409
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
Glaccum, M. B., Stocking, K. L., Charrier, K., Smith, J. L., Willis, C. R., Maliszewski, C., Livingston, D. J., Peschon, J. J., & Morrissey, P. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3364 · Cited by 374
Haskill, S., Martin, G., Van Le, L., Morris, J., Peace, A., Bigler, C. F., Jaffe, G. J., Hammerberg, C., Sporn, S. A., & Fong, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3681 · Cited by 328
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
Hirsch, E., Irikura, V. M., Paul, S. M., & Hirsh, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11008 · Cited by 316
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.
Mountford, P., Zevnik, B., Düwel, A., Nichols, J., Li, M., Dani, C., Robertson, M., Chambers, I., & Smith, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4303 · Cited by 312
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
Kilian, P. L., Kaffka, K. L., Stern, A. S., Woehle, D., Benjamin, W. R., Dechiara, T. M., Gubler, U., Farrar, J. J., Mizel, S. B., & Lomedico, P. T. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4509 · Cited by 285
Purification to apparent homogeneity of murine interleukin 1.
Mizel, S. B., & Mizel, D. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.3.834 · Cited by 257
Arend, W. P., Malyak, M., Smith, M. F., Whisenand, T. D., Slack, J. L., Sims, J. E., Giri, J. G., & Dower, S. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4766 · Cited by 241
Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease
Francis, S. E., Camp, N. J., Dewberry, R. M., Gunn, J., Syrris, P., Carter, N. D., Jeffery, S., Kaski, J. C., Cumberland, D. C., Duff, G. W., et al. (1999) · Circulation · doi:10.1161/01.cir.99.7.861 · Cited by 227
Self-citationIL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently
Arend, W. P., Smith, M. F., Janson, R. W., & Joslin, F. G. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1530 · Cited by 215
Minimally modified low density lipoprotein is biologically active in vivo in mice.
Liao, F., Berliner, J. A., Mehrabian, M., Navab, M., Demer, L. L., Lusis, A. J., & Fogelman, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115261 · Cited by 213
Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M. C., Banchereau, J., Dinarello, C. A., & Miossec, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1432 · Cited by 194
Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells
Joyner, A. L., Skarnes, W. C., & Rossant, J. (1989) · Nature · doi:10.1038/338153a0 · Cited by 194
A critical role for interleukin‐1 receptor accessory protein in interleukin‐1 signaling
Korherr, C., Hofmeister, R., Wesche, H., & Falk, W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270139 · Cited by 175
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells.
Sica, A., Matsushima, K., Damme, J. V., Wang, J. M., Polentarutti, N., Dejana, E., Colotta, F., & Mantovani, A. (1990) · PubMed Central · Cited by 165
Dower, S., Call, S. M., Gillis, S. A., & Urdal, D. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1060 · Cited by 144
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes
Fenton, M. J., Buras, J. A., & Donnelly, R. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1283 · Cited by 142
Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.
Muzio, M., Polentarutti, N., Sironi, M., Poli, G., GIOIA, L. D., Introna, M., Mantovani, A., & Colotta, F. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.623 · Cited by 119
Characterization of a Low Molecular Weight Isoform of IL-1 Receptor Antagonist
Malyak, M., Guthridge, J. M., Hance, K. R., Dower, S., Freed, J. H., & Arend, W. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1997 · Cited by 85
Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents
Beckwith, C. S., Franklin, C. L., Hook, R. R., Besch-Williford, C. L., & Riley, L. K. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1620-1623.1997 · Cited by 73
Gabay, C., Porter, B., Fantuzzi, G., & Arend, W. P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.5905 · Cited by 67
Murine Cytomegalovirus-associated Arteritis
Dangler, C. A., Baker, S. E., Njenga, M. K., & Chia, S. H. (1995) · Veterinary Pathology · doi:10.1177/030098589503200205 · Cited by 27
The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitro
Zahedi, K. A., Uhlar, C., Rits, M., Prada, A. E., & Whitehead, A. S. (1994) · Cytokine · doi:10.1016/1043-4666(94)90001-9 · Cited by 18
Cited by
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“Deficiency of IL-1Ra in mice results in spontaneous and lethal arteritis, destructive arthritis, and psoriatic-like skin lesions, as well as increased susceptibility to carcinogenesis (Horai et al., 2000; Nicklin et al., 2000).”
Anti-inflammatory Agents: Present and Future
Dinarello, C. A. (2010) · Cell · doi:10.1016/j.cell.2010.02.043 · Cited by 1,095
Metadata
- Authors
- Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-01-17
- Volume
- 191
- Issue
- 2
- Pages
- 303-312
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1998574307
- Cited by
- 317
- References
- 33
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.